Division of Cardiology, Cardiovascular and Thoracic Department, Città della Salute e della Scienza Hospital and University of Turin, Italy.
Department of Cardiology, Division of Cardiology, New York-Presbyterian Hospital, Columbia University Medical Center, New York, NY, USA.
Eur Heart J Qual Care Clin Outcomes. 2021 Mar 15;7(2):143-153. doi: 10.1093/ehjqcco/qcaa089.
Permanent pacemaker implantation (PPI) may be required after transcatheter aortic valve implantation (TAVI). Evidence on PPI prediction has largely been gathered from high-risk patients receiving first-generation valve implants. We undertook a meta-analysis of the existing literature to examine the incidence and predictors of PPI after TAVI according to generation of valve, valve type, and surgical risk.
We made a systematic literature search for studies with ≥100 patients reporting the incidence and adjusted predictors of PPI after TAVI. Subgroup analyses examined these features according to generation of valve, specific valve type, and surgical risk. We obtained data from 43 studies, encompassing 29 113 patients. Permanent pacemaker implantation rates ranged from 6.7% to 39.2% in individual studies with a pooled incidence of 19% (95% CI 16-21). Independent predictors for PPI were age [odds ratio (OR) 1.05, 95% confidence interval (CI) 1.01-1.09], left bundle branch block (LBBB) (OR 1.45, 95% CI 1.12-1.77), right bundle branch block (RBBB) (OR 4.15, 95% CI 3.23-4.88), implantation depth (OR 1.18, 95% CI 1.11-1.26), and self-expanding valve prosthesis (OR 2.99, 95% CI 1.39-4.59). Among subgroups analysed according to valve type, valve generation and surgical risk, independent predictors were RBBB, self-expanding valve type, first-degree atrioventricular block, and implantation depth.
The principle independent predictors for PPI following TAVI are age, RBBB, LBBB, self-expanding valve type, and valve implantation depth. These characteristics should be taken into account in pre-procedural assessment to reduce PPI rates. PROSPERO ID CRD42020164043.
经导管主动脉瓣置换术(TAVI)后可能需要植入永久性起搏器(PPI)。关于 PPI 预测的证据主要来自接受第一代瓣膜植入的高危患者。我们对现有文献进行了荟萃分析,以根据瓣膜、瓣膜类型和手术风险检查 TAVI 后 PPI 的发生率和预测因素。
我们对≥100 例报告 TAVI 后 PPI 发生率和调整后预测因素的研究进行了系统的文献检索。亚组分析根据瓣膜、特定瓣膜类型和手术风险检查了这些特征。我们从 43 项研究中获得了数据,共纳入 29113 例患者。在个别研究中,PPI 发生率从 6.7%到 39.2%不等,汇总发生率为 19%(95%CI 16-21)。PPI 的独立预测因素为年龄[比值比(OR)1.05,95%置信区间(CI)1.01-1.09]、左束支传导阻滞(LBBB)(OR 1.45,95%CI 1.12-1.77)、右束支传导阻滞(RBBB)(OR 4.15,95%CI 3.23-4.88)、植入深度(OR 1.18,95%CI 1.11-1.26)和自膨式瓣膜假体(OR 2.99,95%CI 1.39-4.59)。根据瓣膜类型、瓣膜类型和手术风险进行的亚组分析中,独立预测因素为 RBBB、自膨式瓣膜类型、一度房室传导阻滞和植入深度。
TAVI 后 PPI 的主要独立预测因素为年龄、RBBB、LBBB、自膨式瓣膜类型和瓣膜植入深度。在术前评估中应考虑这些特征,以降低 PPI 发生率。PROSPERO ID CRD42020164043。